Fleury S.A. (BVMF: FLRY3)

Market Cap	9.05B
Revenue (ttm)	7.46B
Net Income (ttm)	597.02M
Shares Out	545.59M
EPS (ttm)	1.09
PE Ratio	15.16
Forward PE	12.55
Dividend	0.58 (3.54%)
Ex-Dividend Date	Aug 15, 2024

Volume	2,136,300
Open	n/a
Previous Close	16.47
Day's Range	16.36 - 16.63
52-Week Range	13.69 - 18.96
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Fleury

Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and imaging tests, genomics, health management and platform, diagnostic information, check-up and reference laboratory, clinic day, infusion center, orthopedics and ophthalmology, dental imaging tests, and diagnostic imaging se...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1926
• Employees: 27,300
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: FLRY3

Financial Performance

In 2023, Fleury's revenue was 6.47 billion, an increase of 44.99% compared to the previous year's 4.46 billion. Earnings were 423.76 million, an increase of 37.62%.